To understand the small molecule market in 2026, one must look beyond the broad headlines and analyze the specific segments that are driving value. The market can be segmented by therapeutic area, discovery stage, target class, and service type. While oncology remains the dominant therapeutic segment, we are seeing a significant resurgence in cardiovascular and metabolic disease research. This...